JNCE · Categories · Form 4

JNCE - SEC Form 4 insider transactions

Jounce Therapeutics Inc. (JNCE) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for JNCE

• 1131d
  SEC Form 4 filed by Concentra Biosciences, Llc

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1131d
  SEC Form 4 filed by Tang Kevin C

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1132d
  SEC Form 4 filed by Salter-Cid Luisa

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1132d
  SEC Form 4 filed by Raythatha Jigar

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1132d
  SEC Form 4 filed by Murray Richard /Ca/

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1132d
  SEC Form 4 filed by Karsen Perry A

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1132d
  SEC Form 4 filed by Kamen Robert

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1132d
  SEC Form 4 filed by Iannone Robert

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1132d
  SEC Form 4 filed by Duncan Barbara Gayle

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1132d
  SEC Form 4 filed by Drapkin Kimberlee C

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1132d
  SEC Form 4 filed by Diaz Luis

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1160d
  SEC Form 4 filed by Murray Richard /Ca/

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1183d
  SEC Form 4: Tang Kevin C bought $85,958 worth of shares (85,987 units at $1.00)

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1245d
  SEC Form 4: Trehu Elizabeth sold $10,316 worth of shares (9,285 units at $1.11), decreasing direct ownership by 8% to 103,417 units (for tax liability)

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1245d
  SEC Form 4: Murray Richard /Ca/ sold $50,075 worth of shares (45,070 units at $1.11), decreasing direct ownership by 17% to 228,007 units (tax withholding)

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1245d
  SEC Form 4: Drapkin Kimberlee C sold $15,661 worth of shares (14,096 units at $1.11), decreasing direct ownership by 18% to 66,018 units to satisfy tax liability

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1245d
  SEC Form 4: Cole Hugh M sold $18,481 worth of shares (16,634 units at $1.11), decreasing direct ownership by 13% to 110,082 units to satisfy withholding obligation

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1406d
  SEC Form 4: Cole Hugh M was granted 20,000 shares, increasing direct ownership by 19% to 126,716 units

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1442d
  SEC Form 4 filed by Salter-Cid Luisa

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1442d
  SEC Form 4 filed by Raythatha Jigar

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1442d
  SEC Form 4 filed by Karsen Perry A

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1442d
  SEC Form 4 filed by Kamen Robert

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1442d
  SEC Form 4 filed by Iannone Robert

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1442d
  SEC Form 4 filed by Higgons John Duncan

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1442d
  SEC Form 4 filed by Duncan Barbara Gayle

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1442d
  SEC Form 4 filed by Diaz Luis

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1545d
  SEC Form 4 filed by Cole Hugh M (Amendment)

  4/A - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1587d
  SEC Form 4: Cole Hugh M was granted 42,500 shares, increasing direct ownership by 66% to 106,716 units

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1587d
  SEC Form 4: Drapkin Kimberlee C was granted 27,500 shares, increasing direct ownership by 52% to 80,114 units

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1587d
  SEC Form 4: Murray Richard /Ca/ was granted 87,500 shares, increasing direct ownership by 47% to 273,077 units

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1587d
  SEC Form 4: Trehu Elizabeth was granted 27,500 shares, increasing direct ownership by 32% to 112,702 units

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1610d
  SEC Form 4: Trehu Elizabeth sold $57,700 worth of shares (8,383 units at $6.88), decreasing direct ownership by 9% to 85,202 units (for withholding tax)

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1610d
  SEC Form 4: Murray Richard /Ca/ sold $256,696 worth of shares (37,294 units at $6.88), decreasing direct ownership by 17% to 185,577 units (for tax liability)

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1610d
  SEC Form 4: Drapkin Kimberlee C sold $88,220 worth of shares (12,817 units at $6.88), decreasing direct ownership by 20% to 52,614 units (withholding tax)

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1610d
  SEC Form 4: Cole Hugh M sold $66,580 worth of shares (9,673 units at $6.88), decreasing direct ownership by 13% to 64,216 units (tax liability)

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1666d
  SEC Form 4: Third Rock Ventures Iii, L.P. sold $15,922,000 worth of shares (1,900,000 units at $8.38)

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1666d
  SEC Form 4: Pfeffer Cary sold 0 shares

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1726d
  SEC Form 4 filed by Third Rock Ventures Ii, L.P.

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1726d
  SEC Form 4 filed by Pfeffer Cary

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1728d
  SEC Form 4 filed by Raythatha Jigar

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1813d
  SEC Form 4 filed by Salter-Cid Luisa

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1813d
  SEC Form 4 filed by Pfeffer Cary

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1813d
  SEC Form 4 filed by Kamen Robert

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1813d
  SEC Form 4 filed by Iannone Robert

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1813d
  SEC Form 4 filed by Higgons John Duncan

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1813d
  SEC Form 4 filed by Duncan Barbara Gayle

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1813d
  SEC Form 4 filed by Diaz Luis

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1813d
  SEC Form 4 filed by KARSEN PERRY A

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1821d
  SEC Form 4 filed by Pfeffer Cary

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1821d
  SEC Form 4 filed by Third Rock Ventures II, L.P.

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1839d
  SEC Form 4: Third Rock Ventures II, L.P. sold $4,420,160 worth of Common Stock (552,520 units at $8.00)

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1880d
  SEC Form 4: Higgons John Duncan sold $2,000 worth of Common Stock (200 units at $10.00), decreasing direct ownership by 2% to 9,713 units

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1896d
  SEC Form 4: Elizabeth Trehu exercised 13,500 units of Common Stock at a strike of $4.02 and sold $136,206 worth of Common Stock (13,500 units at $10.09)

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1910d
  SEC Form 4: Duncan John Higgons sold $2,560 worth of Common Stock (200 units at $12.80), decreasing direct ownership by 2% to 9,913 units

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1912d
  SEC Form 4 filed by L.P. Ii, Ventures Rock Third

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1912d
  SEC Form 4 filed by Cary Pfeffer

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1924d
  SEC Form 4: Cary Pfeffer sold $0 worth of Common Stock (0 units at $0.00)

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1924d
  SEC Form 4: L.P. Ii, Ventures Rock Third sold $17,037,500 worth of Common Stock (1,450,000 units at $11.75)

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1937d
  SEC Form 4: Duncan John Higgons sold $2,356 worth of Common Stock (200 units at $11.78), decreasing ownership by 2% to 10,113 units

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)
• 1943d
  SEC Form 4 filed by Luisa Salter-Cid

  4 - Jounce Therapeutics, Inc. (0001640455) (Issuer)

Other JNCE categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends